| The severe asthma network in Italy: findings and perspectives E Heffler, F Blasi, M Latorre, F Menzella, P Paggiaro, G Pelaia, G Senna, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1462-1468, 2019 | 184 | 2019 |
| Deep sequencing analysis reveals that KRAS mutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma F Lococo, G Gandolfi, G Rossi, C Pinto, C Rapicetta, A Cavazza, ... Journal of Thoracic Oncology 11 (8), 1282-1292, 2016 | 82 | 2016 |
| Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases F Menzella, M Lusuardi, C Galeone, S Taddei, L Zucchi Journal of asthma and allergy, 105-114, 2015 | 77 | 2015 |
| A case of chronic eosinophilic pneumonia in a patient treated with dupilumab F Menzella, G Montanari, G Patricelli, A Cavazza, C Galeone, P Ruggiero, ... Therapeutics and clinical risk management, 869-875, 2019 | 73 | 2019 |
| Real-life efficacy of omalizumab after 9 years of follow-up F Menzella, C Galeone, D Formisano, C Castagnetti, P Ruggiero, ... Allergy, Asthma & Immunology Research 9 (4), 368-372, 2017 | 61 | 2017 |
| Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma N Facciolongo, A Di Stefano, V Pietrini, C Galeone, F Bellanova, ... BMC pulmonary medicine 18, 1-11, 2018 | 56 | 2018 |
| Tailored therapy for severe asthma F Menzella, M Lusuardi, C Galeone, L Zucchi Multidisciplinary respiratory medicine 10, 1-8, 2015 | 56 | 2015 |
| Pneumonia and invasive pneumococcal diseases: the role of pneumococcal conjugate vaccine in the era of multi-drug resistance C Scelfo, F Menzella, M Fontana, G Ghidoni, C Galeone, NC Facciolongo Vaccines 9 (5), 420, 2021 | 53 | 2021 |
| Soluble epidermal growth factor receptors (sEGFRs) in cancer: Biological aspects and clinical relevance S Maramotti, M Paci, G Manzotti, C Rapicetta, M Gugnoni, C Galeone, ... International journal of molecular sciences 17 (4), 593, 2016 | 52 | 2016 |
| Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas F Lococo, F Torricelli, G Rossi, M Alifano, D Damotte, C Rapicetta, ... Lung Cancer 113, 93-101, 2017 | 50 | 2017 |
| Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report N Facciolongo, F Menzella, M Lusuardi, R Piro, C Galeone, C Castagnetti, ... Multidisciplinary respiratory medicine 10, 1-4, 2015 | 45 | 2015 |
| Innovative treatments for severe refractory asthma: how to choose the right option for the right patient? F Menzella, C Galeone, F Bertolini, C Castagnetti, N Facciolongo Journal of Asthma and Allergy, 237-247, 2017 | 41 | 2017 |
| The clinical profile of benralizumab in the management of severe eosinophilic asthma F Menzella, M Lusuardi, C Galeone, N Facciolongo, L Zucchi Therapeutic Advances in Respiratory Disease 10 (6), 534-548, 2016 | 39 | 2016 |
| Rehabilitation for lung cancer patients undergoing surgery: results of the PUREAIR randomized trial S Tenconi, C Mainini, C Rapicetta, L Braglia, C Galeone, S Cavuto, ... Eur J Phys Rehabil Med 57 (6), 1002-1011, 2021 | 36 | 2021 |
| Severe refractory asthma: current treatment options and ongoing research F Menzella, F Bertolini, M Biava, C Galeone, C Scelfo, M Caminati Drugs in context 7, 2018 | 35 | 2018 |
| Clinical usefulness of mepolizumab in severe eosinophilic asthma F Menzella, M Lusuardi, G Montanari, C Galeone, N Facciolongo, ... Therapeutics and Clinical Risk Management, 907-916, 2016 | 32 | 2016 |
| Severe asthma: One disease and multiple definitions D Bagnasco, P Paggiaro, M Latorre, C Folli, E Testino, A Bassi, ... World Allergy Organization Journal 14 (11), 100606, 2021 | 31 | 2021 |
| Precision medicine in targeted therapies for severe asthma: is there any place for “omics” technology? C Galeone, C Scelfo, F Bertolini, M Caminati, P Ruggiero, N Facciolongo, ... BioMed research international 2018 (1), 4617565, 2018 | 29 | 2018 |
| Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential F Menzella, M Lusuardi, C Galeone, S Taddei, N Facciolongo, L Zucchi Therapeutic Advances in Chronic Disease 7 (6), 260-277, 2016 | 28 | 2016 |
| Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors? F Menzella, M Biava, D Bagnasco, C Galeone, A Simonazzi, P Ruggiero, ... Drugs in Context 8, 2019 | 27 | 2019 |
